Clinical trial
Randomized Prospective Study Comparing 5% Imiquimod and Photodynamic Therapy for Actinic Cheilitis
NCT00849992 is registered in ClinicalTrials.gov with Norwegian University of Science and Technology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Prospective Study Comparing 5% Imiquimod and Photodynamic Therapy for Actinic Cheilitis
- Lead sponsor
- Norwegian University of Science and Technology
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 31, 2009
- Completion date
- November 30, 2013
- Enrollment
- 53 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
actinic cheilitis